Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoshihiko Ueda

Showing results (71-80 of 150) with videos related to

Pageof 15
Sort By:
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|December 1, 2010
Immunohistochemical detection of fibroblast growth factor receptor 3 in human breast cancer: correlation with clinicopathological/molecular parameters and prognosisKazuko Kuroso, Yasuo Imai, Masashi Kobayashi, et al.
Internal Medicine (Tokyo, Japan)|September 17, 2011
Renovascular protective effects of erythropoietin in patients with chronic kidney diseaseNobuharu Fujiwara, Tsukasa Nakamura, Eiichi Sato, et al.
Metabolism: Clinical and Experimental|March 2, 2010
Oral adsorbent AST-120 ameliorates tubular injury in chronic renal failure patients by reducing proteinuria and oxidative stress generationTsukasa Nakamura, Eiichi Sato, Nobuharu Fujiwara, et al.
Blood Purification|May 19, 2004
Effect of polymyxin B-immobilized fiber on blood metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in acute respiratory distress syndrome patientsTsukasa Nakamura, Yasuhiro Kawagoe, Takaharu Matsuda, et al.
Nephrology (Carlton, Vic.)|January 25, 2005
Effectiveness of high trough levels of cyclosporine for 5 months in a case of steroid-dependent nephrotic syndrome with severe steroid toxicityKenichi Kano, Yumi Yamada, Taeko Shiraiwa, et al.
Journal of Gastroenterology and Hepatology|July 2, 2013
Aberrant cytokeratin expression as a possible prognostic predictor in poorly differentiated colorectal carcinomaHidetsugu Yamagishi, Yasuo Imai, Takuya Okamura, et al.
BMC Research Notes|July 9, 2013
Paclitaxel-resistant advanced recurrent breast cancer: a case of partial response due to addition of bevacizumab to paclitaxel therapy: a case reportKazuo Ishizuna, Jun Ninomiya, Makoto Kojima, et al.
Anticancer Research|January 10, 2014
Expression of cytokeratin 20 indicates invasive histological phenotype in poorly differentiated colorectal adenocarcinomaYasuo Imai, Hidetsugu Yamagishi, Kazunori Fukuda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 12, 2014
Locally advanced breast cancer with bleeding - two cases effectively treated with bevacizumab plus weekly paclitaxelKazuo Ishizuna, Jun Ninomiya, Toshihisa Ogawa, et al.
Internal Medicine (Tokyo, Japan)|November 15, 2021
Anti-MDA5 Antibody-positive Dermatomyositis with Rapidly Progressive Interstitial Pneumonia Presenting with Nephrotic Syndrome during Treatment with Corticosteroids and CyclosporineShinya Kawamoto, Toshihiro Abe, Katsuhiro Nagahori, et al.
Pageof 15

Showing results (71-80 of 150) with videos related to

Sort By:
Pageof 15
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|December 1, 2010
Immunohistochemical detection of fibroblast growth factor receptor 3 in human breast cancer: correlation with clinicopathological/molecular parameters and prognosisKazuko Kuroso, Yasuo Imai, Masashi Kobayashi, et al.
Internal Medicine (Tokyo, Japan)|September 17, 2011
Renovascular protective effects of erythropoietin in patients with chronic kidney diseaseNobuharu Fujiwara, Tsukasa Nakamura, Eiichi Sato, et al.
Metabolism: Clinical and Experimental|March 2, 2010
Oral adsorbent AST-120 ameliorates tubular injury in chronic renal failure patients by reducing proteinuria and oxidative stress generationTsukasa Nakamura, Eiichi Sato, Nobuharu Fujiwara, et al.
Blood Purification|May 19, 2004
Effect of polymyxin B-immobilized fiber on blood metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 levels in acute respiratory distress syndrome patientsTsukasa Nakamura, Yasuhiro Kawagoe, Takaharu Matsuda, et al.
Nephrology (Carlton, Vic.)|January 25, 2005
Effectiveness of high trough levels of cyclosporine for 5 months in a case of steroid-dependent nephrotic syndrome with severe steroid toxicityKenichi Kano, Yumi Yamada, Taeko Shiraiwa, et al.
Journal of Gastroenterology and Hepatology|July 2, 2013
Aberrant cytokeratin expression as a possible prognostic predictor in poorly differentiated colorectal carcinomaHidetsugu Yamagishi, Yasuo Imai, Takuya Okamura, et al.
BMC Research Notes|July 9, 2013
Paclitaxel-resistant advanced recurrent breast cancer: a case of partial response due to addition of bevacizumab to paclitaxel therapy: a case reportKazuo Ishizuna, Jun Ninomiya, Makoto Kojima, et al.
Anticancer Research|January 10, 2014
Expression of cytokeratin 20 indicates invasive histological phenotype in poorly differentiated colorectal adenocarcinomaYasuo Imai, Hidetsugu Yamagishi, Kazunori Fukuda, et al.
Gan to Kagaku Ryoho. Cancer & Chemotherapy|June 12, 2014
Locally advanced breast cancer with bleeding - two cases effectively treated with bevacizumab plus weekly paclitaxelKazuo Ishizuna, Jun Ninomiya, Toshihisa Ogawa, et al.
Internal Medicine (Tokyo, Japan)|November 15, 2021
Anti-MDA5 Antibody-positive Dermatomyositis with Rapidly Progressive Interstitial Pneumonia Presenting with Nephrotic Syndrome during Treatment with Corticosteroids and CyclosporineShinya Kawamoto, Toshihiro Abe, Katsuhiro Nagahori, et al.
Pageof 15